|Day Low/High||10.86 / 11.15|
|52 Wk Low/High||6.50 / 14.09|
We would consider adding to TherapeuticsMD on the next market decline and booking profits in ON Semiconductor into a rally.
We didn't trade in the model portfolio this week, but several of our holdings made big moves so far this year.
We closed out a number of holdings for big gains in 2016, including McDermott, Cott and CECO Environmental.
We didn't make any trades this week but are keeping 40% of the portfolio in cash to add names as opportunities arise.
Investors in Builders FirstSource Inc. saw new options begin trading this week, for the August 2017 expiration.
We bought more TherapeuticsMD and Yamana Gold using proceeds from the sale of some Orasure shares.
We bought shares of TherapeuticsMD but still have a large portion of the portfolio in cash.
We booked some profits in Huntington Bancshares and SLM this week and cut our rating on SLM from One to Two.
Holding an above-average cash position after peeling profits off the table into the most recent rally.
We again have an above-average cash position after peeling profits off the table into the most recent rally.
Builders FirstSource, Huntington Bancshares and TherapeuticsMD all received upbeat outlooks from analysts overnight.
We booked some profits in Synovus Financial and used part of the proceeds to buy more Yamana Gold.
We sold the rest of our Datalink holdings and will use the proceeds to add a name to our portfolio.
We used this week's declines to add to our position in Jive Software and Sonus Networks.
This company is now valued at a discount to projected growth.
These Two-rated holdings are set to report after Thursday's close.
Our screen reveals 17 names that could become oversold and disconnected from their fundamentals as a result of this phenomenon.
We used this week's declines to add to our positions in Teligent, Builders FirstSource and Sonus Networks.
We used this week's declines to add to our positions in Teligent and Sonus Networks.
BLDR is trading 8% lower than our most recent purchase and we are scaling our position size back up.
We're buying more Builders FirstSource and TherapeuticsMD in a market that is starting the day lower.
We used this week's selloff to take positions in a student loan provider and a generic drug maker.